JFS WEALTH ADVISORS, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1568068 HERMITAGE, PA

Position in ARWR

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$1,548

+$1,052 QoQ

Shares Held

-51.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#471

of 497 holders

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

JFS WEALTH ADVISORS, LLC holds $296,395 across 46 Biotechnology names. ARWR ranks #25 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	101	$50,169
2	MRNA	Moderna, Inc.	627	$43,908
3	ARGX	Argenx SE	36	$33,399
4	REGN	Regeneron Pharmaceuticals, Inc.	40	$24,941
5	EXEL	Exelixis, Inc.	293	$15,942
6	JAZZ	Jazz Pharmaceuticals plc	56	$13,494
7	INCY	Incyte Corp	117	$13,263
8	ALNY	Alnylam Pharmaceuticals, Inc.	40	$12,041

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,548	19	-51.3%	Shares	Sole	2026-07-10
2025-03-31	$496	39	-30.4%	Shares	Sole	2025-04-22
2024-12-31	$1,052	56	-31.7%	Shares	Sole	2025-01-31
2024-09-30	$1,588	82	0.0%	Shares	Sole	2024-10-25
2024-06-30	$2,131	82	-7.9%	Shares	Sole	2024-07-15
2024-03-31	$2,545	89	-4.3%	Shares	Sole	2024-04-30
2023-12-31	$2,845	93	-3.1%	Shares	Sole	2024-02-07
2023-09-30	$2,579	96	0.0%	Shares	Sole	2023-11-02
2023-06-30	$3,423	96	0.0%	Shares	Sole	2023-08-07
2023-03-31	$2,438	96	0.0%	Shares	Sole	2023-04-19
2022-12-31	$3,893	96	0.0%	Shares	Sole	2023-02-13
2022-09-30	$3,172	96	0.0%	Shares	Sole	2022-10-21
2022-06-30	$3,380	96	0.0%	Shares	Sole	2022-08-02
2022-03-31	$4,415	96	—	Shares	Sole	2022-05-02
No filing history on record for this holder in this stock.